These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Rescue therapy with mycophenolate mofetil in refractory uveitis. Kilmartin DJ, Forrester JV, Dick AD. Lancet; 1998 Jul 04; 352(9121):35-6. PubMed ID: 9800750 [No Abstract] [Full Text] [Related]
3. Mycophenolate mofetil use in the treatment of noninfectious uveitis. Klisovic DD. Dev Ophthalmol; 2012 Jul 04; 51():57-62. PubMed ID: 22517204 [Abstract] [Full Text] [Related]
5. Time to Uveitis Control with Methotrexate and Mycophenolate Mofetil. Bui AD, Kong CL, Kelly NK, Rathinam SR, Gonzales JA, Thundikandy R, Kanakath A, Murugan B, Vedhanayaki R, Lim LL, Suhler EB, Al-Dhibi HA, Doan T, Acharya NR, First-Line Antimetabolites as Steroid-Sparing Treatment Research Group. Ophthalmology; 2022 Jun 04; 129(6):721-723. PubMed ID: 35085661 [No Abstract] [Full Text] [Related]
6. Cost-Utility Analysis of Mycophenolate Mofetil versus Methotrexate for Noninfectious Uveitis. Al-Khersan H, Fowler BJ, Clauss KD, Kunkler AL, Yannuzzi NA, Patel NA, Sridhar J, Albini TA, Smiddy WE. Ophthalmol Retina; 2021 Dec 04; 5(12):1281-1282. PubMed ID: 34411777 [No Abstract] [Full Text] [Related]
7. Mycophenolate mofetil in animal models of autoimmune disease. Zandman-Goddard G, Shoenfeld Y. Lupus; 2005 Dec 04; 14 Suppl 1():s12-6. PubMed ID: 15803926 [Abstract] [Full Text] [Related]